Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

This study is testing whether giving the standard chemotherapy drugs gemcitabine and nab-paclitaxel on a different schedule — designed to match how the body processes them biologically — works better for people with metastatic pancreatic cancer. **You may be eligible if...** - You have been diagnosed with pancreatic cancer (adenocarcinoma) that has spread to other parts of the body (metastatic) - Your cancer is measurable on a CT or MRI scan - You are not pregnant or breastfeeding - If you are a woman who could become pregnant, you must agree to use effective contraception and have a negative pregnancy test before starting treatment **You may NOT be eligible if...** - You have a different type of pancreatic tumour (such as an islet cell tumour, not adenocarcinoma) - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.